Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia

Clinical Infectious Diseases

Volumn 34, Issue 11, 2002, Pages 1425-1430

  Wood, G Christopher ^a   Hanes, Scott O ^a   Croce, Martin A ^b   Fabian, Timothy C ^b   Boucher, Bradley A ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF PHARMACY   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CILASTATIN PLUS IMIPENEM; SULTAMICILLIN;

ACINETOBACTER; ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; CRITICAL ILLNESS; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VENTILATOR;

ACINETOBACTER; ADULT; AMPICILLIN; CILASTATIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMIPENEM; MALE; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES; SULBACTAM; TREATMENT OUTCOME; VENTILATORS, MECHANICAL;

EID: 0036604111     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/340055     Document Type: Article

References (25)

1. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies: A consensus statement
2. Nosocomial pneumonia and mortality among patients in intensive care units
3. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay
4. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome: Incidence, prognosis, and risk factors
5. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients
6. Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: A prospective study
7. Problem pathogens (Pseudomonas aeruginosa and Acinetobacter)
8. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997-1999)
9. Effect of sulbactam on infection caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus
10. Monotherapy versus β-lactam-aminoglycoside combination treatment for gram-negative bacteremia: A prospective, observational study
11. Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: A multicenter randomized controlled trial
12. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients
13. Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients
14. Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections
15. Analysis of aminoglycosides in the treatment of gram-negative infections in surgical patients
16. Clinical criteria in the diagnosis of ventilator-associated pneumonia
17. Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam
18. Bacteremia due to Acinetobacter baumannii: Epidemiology, clinical findings, and prognostic features
19. Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam
20. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii
21. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii
22. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
23. Meropenem: A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy
24. Imipenem, doxycycline and amikacin in monotherapy in combination in Acinetobacter baumannii experimental pneumonia